MicroParticle Proteomics Licenses Cardio Disease Biomarker from UVA Patent Foundation

The biomarker was discovered by former UVA researcher and company co-founder Klaus Ley using a proteomics platform that he also developed while at the university and upon which MPP was founded.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.